v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 22,186 $ 8,469 $ 42,506 $ 21,011
Research and development - related party 150 150 300 300
General and administrative 2,267 2,960 4,236 6,392
Total operating expenses 24,603 11,579 47,042 27,703
Loss from operations (24,603) (11,579) (47,042) (27,703)
Other income, net 1,465 330 2,141 798
Net loss before taxes (23,138) (11,249) (44,901) (26,905)
Income tax expense (193) 0 (566) 0
Net loss $ (23,331) $ (11,249) $ (45,467) $ (26,905)
Net loss per share - basic $ (0.97) $ (0.96) $ (2.18) $ (2.32)
Net loss per share - diluted $ (0.97) $ (0.96) $ (2.18) $ (2.32)
Weighted average shares and pre-funded warrants outstanding, basic 23,787,713 11,744,143 20,828,996 11,572,510
Weighted average shares and pre-funded warrants outstanding, diluted 23,787,713 11,744,143 20,828,996 11,572,510
Comprehensive Loss:        
Net loss $ (23,331) $ (11,249) $ (45,467) $ (26,905)
Unrealized loss on available-for-sale securities, net (50) 0 (57) (11)
Comprehensive loss $ (23,381) $ (11,249) $ (45,524) $ (26,916)